MKI67 and breast carcinoma: The assay revealed that compounds 9 and 10, which formerly showed antiproliferative effects in MCF-7 in vitro, also significantly decreased expression of the antigen Ki-67 and thus inhibited the proliferation of MCF-7 breast cancer xenografts (Figure 5a,b).